WHO Collaborating Centre for Antimicrobial Resistance, Consumption and Health Care-Associated Infections

The Robert Koch Institute (RKI) has been granted by the World Health Organization (WHO) the status of a Collaborating Centre for Antimicrobial Resistance, Consumption and Health Care-Associated Infections on 1st February 2022.

This WHO Collaborating Centre at the RKI aims to support WHO and its Member States in responding to the threat of antimicrobial resistance (AMR) by strengthening surveillance, prevention and control efforts.
Specifically, there are three Terms of Reference for the Collaborating Centre on AMR, Consumption and Health Care-Associated Infections:

• Support WHO in coordination activities to strengthen Member States’ national capacity for the integration of surveillance of antimicrobial resistance, antimicrobial use and consumption and health care-associated infections and contribution to the Global Antimicrobial Resistance Surveillance and Use System (GLASS) as well as regional antimicrobial resistance surveillance networks.
• Upon WHO's request, support WHO’s activities with the continuous overall development and implementation of Global Antimicrobial Resistance Surveillance and Use System (GLASS).
• Support WHO in its activities of the implementation of integrated antimicrobial resistance, antimicrobial use and consumption, and health care-associated infections activities at national level.

The WHO CC for AMR, Consumption and Health Care-Associated Infections is a member of the WHO AMR Surveillance and Quality Assessment Collaborating Centres Network (or WHO AMR Surveillance CC Network). Since 2019 the RKI supports the coordination of the network. The network comprises more than 25 WHO CCs focused on AMR surveillance worldwide and primarily supports Low-and Middle-Income Countries to build capacity to develop and implement AMR surveillance.

Head of the WHO CC

Dr. Tim Eckmanns, Head of unit FG 37 Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption

Dr. Anne Harant, FG 37 Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption

Dr. Sara Tomczyk, FG 37 Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption

Coordination

This Collaborating Centre at the RKI is located at unit FG 37 Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption at the Department of Infectious Disease Epidemiology.